CASE_STUDY
The effects of L-carnitin in Budd-Chiari syndrome in a domestic cat
This paper describes a thrombosis in the vena cava caudalis of a 15 year-old cat with ascites. Trauma and eventually feline enteric corona virus infection in the cat were not detected. In the intrahepatic region, a blockage of vena cava caudalis was brought to light by ultrasonographic imaging. An aspirate of abdominal fl uid revealed modified transudate. Liver enzyme levels were increased in the serum sample of the cat. The levels of total oxidant status (TOS) and total antioxidant status (TAS) were elevated in the peritoneal fluid. Liver protection diet with L-carnitine, diuretic therapy and antimicrobial drugs were administrated for treatment of the cat. During the continuous treatment, the amount of abdominal fluid decreased, but never completely absorbed. L-carnitine was administered to the cat during the time of treatment, and subsequently the levels of liver enzymes decreased. However, the cat died because of recurrent ascites and persistent thrombosis. In conclusion, ultrasonographic examination was very reliable, non-invasive and highly useful diagnostic method for BCS and L-carnitine has crucial effects on the quality of life, energy metabolism and liver enzyme levels. However, the blockage of the vena cava caudalis could not completely respond to medical treatment and thrombosis should be eliminated by surgical intervention.
https://macvetrev.mk/Files/Article/2020/10.1515/macvetrev-2015-0066/macvetrev-2015-0066.pdf
2016-03-15T09:00:00
123
127
10.2478/macvetrev-2015-0066
Budd-Chiari syndrome
cat
L-carnitine
peritoneal fluid
Aliye
Sağkan
Öztürk
false
1
Department of Internal Medicine, Faculty of Veterinary Medicine,Mustafa Kemal University, 31040, Hatay, Turkey
AUTHOR
Nuri
Altuğ
false
2
Department of Internal Medicine, Faculty of Veterinary Medicine,Namık Kemal University, 59030, Tekirdağ, Turkey
AUTHOR
Serkan
İrfan
Köse
srknirfn@gmail.com
false
3
Department of Internal Medicine, Faculty of Veterinary Medicine,Mustafa Kemal University, 31040, Hatay, Turkey
LEAD_AUTHOR
Oktay
Hasan
Öztürk
false
4
Department of Biochemistry, Faculty of Medicine, Akdeniz University,07985, Antalya, Turkey
AUTHOR
Simpson, I.W. (1982). Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterol. 82, 171-178.
1
Stanley, P. (1989). Budd-Chiari syndrome. Radiol. 170, 625-627. PMid:2644657
2
10.1148/radiology.170.3.2644657
Nakamura T., Nakamura S., Aikawa T., Suziki, O., Onodera, A., Karoji, N. (1968). Obstruction of the inferior vena cava in the hepatic portion and the hepatic veins. Angiol. 19(8): 479-500.
3
10.1177/000331976801900805
Amesur, N.B., Zajko, A.B. (2006). Interventional radiology in liver transplantation. Liver Transpl Surg. 12, 330-351. PMid:16498660
4
10.1002/lt.20731
Zhang, X., Qing-Le, L. (2007). Etiology, treatment, and classification of Budd-Chiari syndrome. Chin Med J. 120, 159-161.
5
10.3901/JME.2007.04.159
Durgut, R., Ataseven, V.S., Sagkan-Ozturk, A., Ozturk, O.H. (2013). Evaluation of total oxidative stress and total antioxidant status in cows with natural bovine herpesvirus-1 infection. J Anim Sci. 91, 1–5. PMid:23798525
6
10.2527/jas.2012-5516
Erel, O. (2004). A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 37, 112-119. PMid:14725941
7
10.1016/j.clinbiochem.2003.10.014
Erel, O. (2005). A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 38, 1103-1111. PMid:16214125
8
10.1016/j.clinbiochem.2005.08.008
Schrope, D.S. (2010). Hepatic vein stenosis (Budd-Chiari syndrome) as a cause of ascites in a cat. J Vet Cardiol. 12, 197-202. PMid:21078565
9
10.1016/j.jvc.2010.05.002
Okuda, K., Kage, M., Shrestha, S.M. (1998). Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 28, 1191-1198. PMid:9794901
10
10.1002/hep.510280505
Okuda, K. (2001). Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol. 16, 1179-1183. PMid:11903732
11
10.1046/j.1440-1746.2001.02577.x
Takayasu, K., Muramatsu, Y., Moriyama, N., Wakao, F., Makuuchi, M., Takayama, T., Kosuge, T., Okazaki, N., Yamada, R. (1994). Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma: a report of four cases. Am J Gastroenterol. 88, 249-253.
12
Horoz, M., Bolukbas, C., Bolukbas, F.F., Aslan, M., Koylu, A.O., Selek, S., Erel, O. (2006). Oxidative stres in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis. 6, 114. PMid:16842626 PMCid:PMC1543638
13
10.1186/1471-2334-6-114
Karaagac, L., Koruk, S.T., Koruk, I., Aksoy, N. (2011). Decreasing oxidative stress in response to treatment in patients with brucellosis: could it be used to monitor treatment. Int J Infect Dis. 15(5): 346-349. PMid:21376649
14
10.1016/j.ijid.2011.01.009
Karsen, H., Sunnetcioglu, M., Ceylan, R.M. (2011). Evaluation of oxidative status in patients with Fasciola hepatica infection. Afr Health Sci. 11(1): 14-18.
15
10.4314/ahs.v11i3.70064
Maden, M., Ozturk, S.A., Bulbul, A., Avci, G.,Yazar, E. (2012). Acute phase proteins, oxidative stress and enzyme activities of blood serum and peritoneal fluid in abomasal displacement cases. J Vet Intern Med. 26, 1470–1475. PMid:23113812
16
10.1111/j.1939-1676.2012.01018.x
Braun, U. (2008). Clinical findings and diagnosis of thrombosis of the caudal vena cava in cattle. The Vet J. 175, 118–125. PMid:17239635
17
10.1016/j.tvjl.2006.11.013
Fisher, N.C., Mccafferty, I., Dolapci, M., Wali, M., Buckels, J.A.C., Olliff, S.P., Elias, E. (1999). Managing Budd-Chiari syndrome: a restrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 44, 568-574. PMid:10075967 PMCid:PMC1727471
18
10.1136/gut.44.4.568
Lin, X.H., Jiao, L.L., Xu, G.B., Tian, G.S. (2006). Significance of serum carnitine in patients with liver diseases. Zhonghua Gan Zang Bing ZaZhi, 14(5): 367-369.
19
Malaguarnera, M., Vacante, M., Giordano, M., Motta, M., Bertino, G., Pennisi, M., Neri, S., Malaguernera, M., Li Volti, G., Galvano, F. (2011). L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin. World J Gastroenterol. 17(39): 4414-4420. PMid:22110268 PMCid:PMC3218156
20
10.3748/wjg.v17.i39.4414
Cekin, AH., Gur, G., Turkoglu, S., Aldemir, D., Yılmaz, U., Gursoy, M., Taskoparan, M., Boyacıoğlu, S. (2013). The protective effect of L-carnitine on hepatic ischemia-reperfusion injury in rats. Turk J Gastroenterol. 24 (1): 51-56. PMid:23794344
21